Cargando…

Natural Products for the Treatment of Pulmonary Hypertension: Mechanism, Progress, and Future Opportunities

Pulmonary hypertension (PH) is a lethal disease due to the remodeling of pulmonary vessels. Its pathophysiological characteristics include increased pulmonary arterial pressure and pulmonary vascular resistance, leading to right heart failure and death. The pathological mechanism of PH is complex an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zeng, Zuomei, Wang, Xinyue, Cui, Lidan, Wang, Hongjuan, Guo, Jian, Chen, Yucai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047369/ https://www.ncbi.nlm.nih.gov/pubmed/36975522 http://dx.doi.org/10.3390/cimb45030152

Ejemplares similares

Deciphering the Mechanism of Wogonin, a Natural Flavonoid, on the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Integrating Network Pharmacology and In Vitro Validation
por: Cui, Lidan, et al.
Publicado: (2023)

Ameliorative Effects and Mechanism of Buyang Huanwu Decoction on Pulmonary Vascular Remodeling: Network and Experimental Analyses
por: Chen, Yucai, et al.
Publicado: (2021)

Stem cell therapy in pulmonary hypertension: current practice and future opportunities
por: Zheng, Ruixuan, et al.
Publicado: (2023)

Systematic Elucidation of the Mechanism of Genistein against Pulmonary Hypertension via Network Pharmacology Approach
por: Chen, Yucai, et al.
Publicado: (2019)

Editorial: Pulmonary Hypertension: Mechanisms and Management, History and Future
por: Thompson, A. A. Roger, et al.
Publicado: (2020)

Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension
por: Yu, Zhijie, et al.
Publicado: (2022)

Natural plant products in treatment of pulmonary arterial hypertension
por: Xiang, Lili, et al.
Publicado: (2018)

Group 3 pulmonary hypertension: Challenges and opportunities
por: McGettrick, Michael, et al.
Publicado: (2020)

Nano Functional Food: Opportunities, Development, and Future Perspectives
por: Su, Qijun, et al.
Publicado: (2022)

New progress in diagnosis and treatment of pulmonary arterial hypertension
por: Zhang, Zai-qiang, et al.
Publicado: (2022)

Drug repositioning in pulmonary arterial hypertension: challenges and opportunities
por: Grinnan, Daniel, et al.
Publicado: (2019)

Diagnostic advances and opportunities in chronic thromboembolic pulmonary hypertension
por: D'Armini, Andrea M.
Publicado: (2015)

Disease Burden: Progresses Made, Current State, Future Challenges, and Opportunities
por: Wang, Haidong
Publicado: (2022)

Exploring Natural Products as Radioprotective Agents for Cancer Therapy: Mechanisms, Challenges, and Opportunities
por: Zhang, Yi, et al.
Publicado: (2023)

Radiomics in liver diseases: Current progress and future opportunities
por: Wei, Jingwei, et al.
Publicado: (2020)

Pulmonary hypertension: Past, present and future
por: Barst, Robyn J.
Publicado: (2008)

Future perspectives in pulmonary arterial hypertension
por: Simonneau, Gérald, et al.
Publicado: (2016)

Natural Products and Their Mimics as Targets of Opportunity for Discovery
por: Martin, Stephen F.
Publicado: (2017)

Natural products in drug discovery: advances and opportunities
por: Atanasov, Atanas G., et al.
Publicado: (2021)

Research Progress on the Antiosteoarthritic Mechanism of Action of Natural Products
por: Gao, Mingzhu, et al.
Publicado: (2021)

Salivary Gland Branching Morphogenesis — Recent Progress and Future Opportunities
por: Hsu, Jeff Chi-feng, et al.
Publicado: (2010)

Chinese medicine in the treatment of autoimmune hepatitis: Progress and future opportunities
por: Liu, Jia, et al.
Publicado: (2022)

Epigenome guided crop improvement: current progress and future opportunities
por: Zhang, Yan, et al.
Publicado: (2022)

Graph-Driven Reaction Discovery: Progress, Challenges, and Future Opportunities
por: Ismail, Idil, et al.
Publicado: (2022)

Rehabilitation pre- and post thoracic surgery: Progress and future opportunities
por: Rozenberg, Dmitry
Publicado: (2023)

Natural Products in Cancer Therapy: Past, Present and Future
por: Huang, Min, et al.
Publicado: (2021)

Acute vasodilator testing: An opportunity to advance the precision care of pulmonary hypertension
por: Cirulis, Meghan M., et al.
Publicado: (2019)

The Match of Electrocardiogram and Artificial Intelligence Confers an Opportunity for Pulmonary Hypertension Screening
por: Tu, Shengxian, et al.
Publicado: (2022)

Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities
por: Hu, Weilei, et al.
Publicado: (2019)

Research Progress on the Mechanism of Natural Product Ingredients in the Treatment of Uveitis
por: Li, Sicong, et al.
Publicado: (2021)

The Future of Prescription Drug Cost-Sharing: Real Progress or Dropped Opportunity?
por: Fairman, Kathleen A.
Publicado: (2008)

Editorial: Advances in understanding the mechanisms of pulmonary hypertension
por: Ahmad, Ashfaq, et al.
Publicado: (2023)

Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives
por: Collum, Scott D., et al.
Publicado: (2017)

Construction of an anoikis-associated lncRNA-miRNA-mRNA network reveals the prognostic role of β-elemene in non-small cell lung cancer
por: Tan, Kai, et al.
Publicado: (2023)

Epigenetic mechanisms of pulmonary hypertension
por: Kim, Gene H., et al.
Publicado: (2011)

The mechanism of ions in pulmonary hypertension
por: Liu, Guogu, et al.
Publicado: (2021)

Glycan Mimetics from Natural Products: New Therapeutic Opportunities for Neurodegenerative Disease
por: Wang, Wenyue, et al.
Publicado: (2019)

Precision medicine: The future of diagnostic approach to pulmonary hypertension?
por: Kedzierski, Piotr, et al.
Publicado: (2019)

Persistent Pulmonary Hypertension: A Look Into the Future Therapy
por: Soni, Mridul, et al.
Publicado: (2021)

Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension
por: Hajra, Adrija, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iit5hvlcfckuf6k36e06hn6a50